Publications by authors named "Birgit Deutsch"

Claim this Profile
T
The Prevalence of Potentially Inappropriate Medication in Geriatric Inpatients According to the PRISCUS 2.0 List.
Melanie I Then, Birgit Deutsch, Thomas Tümena, Petra A Thürmann, Martin F Fromm

Dtsch Arztebl Int· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N -Methylnicotinamide as Biomarker for MATE-Mediated Renal Drug-Drug Interactions: Impact of Cimetidine, Rifampin, Verapamil, and Probenecid.
Fabian Müller, Kathrin Hohl, Sascha Keller, Sven Schmidt-Gerets, Birgit Deutsch

Clin Pharmacol Ther· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer Agents.
Pauline Dürr, Katja Schlichtig, Carolin Kelz, Birgit Deutsch, Renke Maas

J Clin Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of 24 circulating endocannabinoids, endocannabinoid-related compounds, and their phospholipid precursors in human plasma by UHPLC-MS/MS.
Waldemar Röhrig, Susanne Achenbach, Birgit Deutsch, Monika Pischetsrieder

J Lipid Res· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efavirenz reduces renal excretion of lamivudine in rats by inhibiting organic cation transporters (OCT, Oct) and multidrug and toxin extrusion proteins (MATE, Mate).
Martina Ceckova, Josef Reznicek, Birgit Deutsch, Martin F Fromm, Frantisek Staud

PLoS One· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interplay of the Organic Cation Transporters OCT1 and OCT2 with the Apically Localized Export Protein MATE1 for the Polarized Transport of Trospium.
Birgit Deutsch, Claudia Neumeister, Ulrich Schwantes, Martin F Fromm, Jörg König

Mol Pharm· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis